[144] SunOpta, Inc. SEC Filing

Rhea-AI Filing Summary

SunOpta, Inc. (STKL) filed a Form 144 reporting a proposed sale of 47,500 common shares with an aggregate market value of $295,469. The filing lists the sale as planned for 08/11/2025 on NASDAQ and shows 118,186,075 shares outstanding, allowing readers to see the absolute size of the notice.

The shares identified were acquired through various compensation programs and purchases between 2017 and 2025, mainly by restricted stock vesting and an employee stock purchase plan; specific lots and acquisition dates are listed. The filing reports Nothing to Report for securities sold during the past three months and includes the filer’s certification that no undisclosed material adverse information is known.

Insights

Financial Analyst

TL;DR: Insider plans to sell 47,500 STKL shares worth about $295k; this equals roughly 0.04% of outstanding shares.

The Form 144 discloses a proposed sale of 47,500 common shares with an aggregate market value of $295,469, to be sold on 08/11/2025 on NASDAQ. Using the filing’s figures, the lots for sale represent approximately 0.04% of the 118,186,075 shares outstanding. The notice is a routine disclosure of an intended sale by a person whose holdings were predominantly acquired via restricted stock vesting and an ESPP; there are no reported insider sales in the prior three months.

Corporate Governance Expert

TL;DR: Routine Form 144 filing showing sales from compensation-related holdings; filer affirms no undisclosed material adverse information.

The schedule of acquisitions in the filing details multiple lots acquired through restricted stock vesting and an employee stock purchase plan between 2017 and 2025, with specific share counts and dates provided. The filing includes the standard signer representation regarding absence of undisclosed material adverse information and lists Nothing to Report for sales in the past three months, consistent with routine compliance disclosures rather than an unusual governance event.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	47500	295469.00	118186075	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2025	Restricted stock vesting under a registered plan	Issuer			2546	04/01/2025	Services Rendered
Common	04/30/2025	Restricted stock vesting under a registered plan	Issuer			87	04/30/2025	Services Rendered
Common	03/31/2023	Restricted stock vesting under a registered plan	Issuer			13393	03/31/2023	Services Rendered
Common	09/01/2017	Shares Purchased through Employee Stock Purchase Plan	Issuer			74	09/01/2017	Cash
Common	04/15/2022	Restricted stock vesting under a registered plan	Issuer			436	04/15/2022	Services Rendered
Common	04/01/2024	Restricted stock vesting under a registered plan	Issuer			9517	04/01/2024	Services Rendered
Common	04/04/2025	Restricted stock vesting under a registered plan	Issuer			8212	04/04/2025	Services Rendered
Common	04/15/2024	Restricted stock vesting under a registered plan	Issuer			487	04/15/2024	Services Rendered
Common	07/10/2024	Restricted stock vesting under a registered plan	Issuer			1243	07/10/2024	Services Rendered
Common	04/15/2023	Restricted stock vesting under a registered plan	Issuer			488	04/15/2023	Services Rendered
Common	04/01/2022	Restricted stock vesting under a registered plan	Issuer			1584	04/01/2022	Services Rendered
Common	03/06/2023	Restricted stock vesting under a registered plan	Issuer			2591	03/06/2023	Services Rendered
Common	05/25/2023	Restricted stock vesting under a registered plan	Issuer			6842	05/25/2023	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does SunOpta's (STKL) Form 144 report?

The Form 144 reports a proposed sale of 47,500 common shares with an aggregate market value of $295,469, planned for 08/11/2025 on NASDAQ.

How were the shares being sold acquired?

The filing shows shares acquired primarily through restricted stock vesting and an Employee Stock Purchase Plan (ESPP) on multiple dates between 2017 and 2025, with specific lots and amounts listed.

What portion of the company do the 47,500 shares represent?

Based on the filing’s 118,186,075 shares outstanding, the 47,500 shares represent approximately 0.04% of outstanding common stock.

Has this person sold any SunOpta shares in the past three months?

No. The filing states Nothing to Report under securities sold during the past three months.

Where will the sale be executed?

The sale is reported as planned to occur on NASDAQ.